ESO26

Biochem/physiol Actions
Adenocarcinoma of the gastroesophageal junction
ESO26 was established from a primary tumour located in the gastroesophageal junction and distal oesophagus of a 56 year-old Caucasian male in 2000 involving lymph nodes and distant metastases. ESO26 was found to be tumourigenic in female NMRI nude mice or NOD-SCID mice.
STR-PCR Data:

Amelogenin: X,Y
CSF1PO: 9,10
D13S317: 9,11
D16S539: 9
D5S818: 12
D7S820: 11
THO1: 9
TPOX: 7,9
vWA: 14,18
Packaging
NOTE: Both the cell line and DNA from the cell line may be available for this product. Please choose -1VL or VIAL for cells, or -DNA-5UG for DNA.
Preparation Note
RPMI-1640 + 2 mM Glutamine + 10% Foetal Bovine Serum (FBS)
Maintain cultures between 2-9 x 105 cells/cm3. Cells are loosely adherent and can be dislodged by gentle tapping or use of 0.02% EDTA solution. 5% CO2; 37 °C.
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
Cultures from HPA Culture Collections and supplied by Sigma are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.
Disclaimer
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.